Autonomic Nervous System Drugs Practice Questions

Q: Which of the following is NOT an effect of atropine?

Bradycardia. **Explanation:** Atropine is a classic **competitive muscarinic antagonist**. To understand its effects, remember that it blocks the "Rest and Digest" parasympathetic system, leading to "Sympathetic-like" outcomes. **Why Bradycardia is the correct answer:** Atropine typically causes **tachycardia** (increased heart rate) by blocking $M_2$ receptors on the SA node, thereby removing the vagal "brake" on the heart. While very low doses of atropine can cause transient initial bradycardia (due to blockade of presynaptic inhibitory $M_1$ receptors on vagal nerve endings), its **primary, definitive clinical effect is tachycardia**. Therefore, bradycardia is not considered a standard effect of atropine. **Analysis of other options:** * **A. Rise of body temperature:** Atropine inhibits sweat glands ($M_3$ blockade). In children, this can lead to "Atropine fever" because the body cannot dissipate heat through evaporation. * **B. Decreased salivary secretion:** Atropine is a potent antisialogogue. It blocks $M_3$ receptors on salivary glands, leading to a dry mouth (xerostomia). * **C. Increased A-V conduction:** By blocking vagal influence at the Atrioventricular (AV) node, atropine shortens the refractory period and increases conduction velocity. This is why it is used in certain types of heart block. **High-Yield NEET-PG Pearls:** 1. **Drug of Choice:** Atropine is the DOC for **symptomatic sinus bradycardia** and **Organophosphate poisoning**. 2. **Mnemonic for Atropine Toxicity:** "Hot as a hare (fever), Red as a beet (flushing), Dry as a bone (no sweat/saliva), Blind as a bat (cycloplegia/mydriasis), and Mad as a hatter (delirium)." 3. **Contraindication:** Strictly avoided in patients with **Angle-closure Glaucoma** (due to mydriasis causing increased intraocular pressure) and **Benign Prostatic Hyperplasia** (due to risk of urinary retention).

Q: What is the effect of vagal stimulation on the heart?

Increased RR interval in ECG. **Explanation:** The vagus nerve provides **parasympathetic** innervation to the heart, primarily via the release of **Acetylcholine (ACh)**. ACh acts on **M2 muscarinic receptors** located predominantly in the SA and AV nodes. 1. **Why Option B is Correct:** Vagal stimulation causes **negative chronotropy** (decreased heart rate). It achieves this by hyperpolarizing the nodal cells and slowing the rate of phase 4 spontaneous depolarization. On an ECG, a decrease in heart rate directly manifests as an **increase in the RR interval** (the time between two successive R waves). 2. **Why Incorrect Options are Wrong:** * **Option A:** Increased heart rate (positive chronotropy) is a result of **Sympathetic** stimulation (Beta-1 receptors), not vagal. * **Option C:** Cardiac output (CO = Stroke Volume × Heart Rate) **decreases** with vagal stimulation because the heart rate drops significantly. * **Option D:** Increased force of contraction (positive inotropy) is a sympathetic effect. Vagal fibers have minimal innervation of the ventricles; thus, their effect on ventricular contractility is negligible compared to their effect on rate. **High-Yield Clinical Pearls for NEET-PG:** * **Vagal Maneuvers:** Carotid sinus massage or the Valsalva maneuver increases vagal tone and is used clinically to terminate **Supraventricular Tachycardia (SVT)** by slowing AV node conduction. * **Atropine:** A muscarinic antagonist used to treat symptomatic bradycardia because it blocks vagal influence ("vagolytic"). * **Reflex Bradycardia:** Drugs that cause sudden vasoconstriction (like Phenylephrine) trigger a baroreceptor reflex, leading to increased vagal tone and a compensatory increase in the RR interval.

Q: Which glaucoma drug is a beta-1 selective beta-blocker?

Betaxolol. Betaxolol is a **cardioselective (Beta-1 selective)** adrenergic antagonist [2]. In the management of glaucoma, it works by blocking $\beta_1$ receptors on the ciliary epithelium, thereby reducing the production of aqueous humor and lowering intraocular pressure (IOP) [1]. Because it is $\beta_1$ selective, it carries a lower risk of inducing bronchospasm compared to non-selective agents, making it the preferred beta-blocker for patients with co-existing respiratory conditions like asthma or COPD (though it should still be used with caution) [1]. **2. Analysis of Incorrect Options:** * **Timolol (A):** The "Gold Standard" for glaucoma treatment, but it is a **non-selective** beta-blocker ($\beta_1 + \beta_2$). It is contraindicated in patients with asthma/COPD due to the risk of life-threatening bronchospasm from $\beta_2$ blockade. * **Levobunolol (B):** A potent **non-selective** beta-blocker similar to Timolol, often used for its long duration of action. * **Carteolol (C):** A **non-selective** beta-blocker that possesses **Intrinsic Sympathomimetic Activity (ISA)**. It is unique because it may cause less bradycardia and has a "membrane-stabilizing" effect, but it is not $\beta_1$ selective. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** Remember **"B"** for **B**etaxolol is **B**eta-1 selective. * **Efficacy:** While safer for the lungs, Betaxolol is slightly **less effective** at lowering IOP compared to Timolol. * **Side Effects:** Local side effects of topical beta-blockers include stinging, burning, and dry eyes. Systemic absorption can lead to bradycardia and heart block. * **Contraindications:** All topical beta-blockers are generally contraindicated in patients with 2nd or 3rd-degree heart block or severe bradycardia.

Q: What is the recommended treatment for atropine toxicity?

Physostigmine. **Explanation:** **Correct Answer: D. Physostigmine** **Mechanism of Action:** Atropine toxicity is characterized by competitive antagonism of muscarinic receptors (causing symptoms like "mad as a hatter, dry as a bone, red as a beet"). **Physostigmine** is the drug of choice because it is a **tertiary amine** acetylcholinesterase inhibitor. Unlike other carbamates (like Neostigmine), Physostigmine is lipid-soluble and **crosses the blood-brain barrier (BBB)**. This allows it to reverse both the peripheral and the life-threatening central anticholinergic effects (delirium, seizures, coma) of atropine. **Analysis of Incorrect Options:** * **A. 2-Pralidoxime (2-PAM):** This is a cholinesterase reactivator used specifically for **Organophosphate poisoning**. It would worsen atropine toxicity as atropine is actually used as an antidote for OP poisoning. * **B. Naloxone:** A competitive opioid antagonist used to reverse **Opioid overdose** (respiratory depression/miosis). * **C. Flumazenil:** A competitive GABA-A receptor antagonist used to reverse **Benzodiazepine overdose**. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Atropine Toxicity:** "Hot as a hare (hyperthermia), Red as a beet (flushing), Dry as a bone (anhidrosis), Blind as a bat (mydriasis/cycloplegia), Mad as a hatter (delirium)." * **Why not Neostigmine?** Neostigmine is a quaternary ammonium compound; it does not cross the BBB and therefore cannot treat the central CNS symptoms of atropine toxicity. * **Contraindication:** Physostigmine should be avoided in Tricyclic Antidepressant (TCA) overdose as it may aggravate cardiac conduction defects.

Q: Latanoprost is used for which of the following conditions?

Glaucoma. **Explanation:** **Latanoprost** is a synthetic analog of **Prostaglandin F2̱ (PGF2̱)** [1]. It is the first-line treatment for **Open-Angle Glaucoma** and ocular hypertension [1],[2]. **Why Option D is Correct:** Latanoprost acts as a selective agonist at **FP receptors** [2]. Its primary mechanism of action in the eye is increasing the **uveoscleral outflow** of aqueous humor (rather than affecting the trabecular meshwork) [1]. By facilitating the drainage of fluid through the ciliary muscle into the suprachoroidal space, it effectively lowers intraocular pressure (IOP) [1]. **Why Other Options are Incorrect:** * **A. Maintenance of ductus arteriosus:** This is achieved using **Alprostadil (PGE1)** [1]. Conversely, NSAIDs like Indomethacin are used to close a patent ductus arteriosus. * **B. Pulmonary hypertension:** While prostaglandins are used here, the specific drugs are **Epoprostenol (PGI2)** or its analogs like Treprostinil and Iloprost [1]. * **C. Gastric mucosal protection:** This is the clinical use of **Misoprostol (PGE1 analog)**, which increases bicarbonate/mucus secretion and inhibits gastric acid [1]. **Clinical Pearls for NEET-PG:** 1. **Side Effects:** A high-yield side effect of Latanoprost is **increased brown pigmentation of the iris** and **hypertrichosis** (thickening and darkening of eyelashes). 2. **Dosing:** It is preferred because of its once-daily dosing schedule, which improves patient compliance. 3. **Other Analogs:** Bimatoprost and Travoprost share the same mechanism. Bimatoprost is also FDA-approved for treating eyelash hypotrichosis.

Q: Edrophonium binds to which site of Acetylcholinesterase?

Anionic site. **Explanation:** The enzyme Acetylcholinesterase (AChE) has two primary binding domains: the **Anionic site** (containing glutamate) and the **Esteric site** (containing a serine residue) [1]. **Why Option A is Correct:** Edrophonium is a quaternary ammonium compound. It binds **only to the Anionic site** of the enzyme through reversible ionic/electrostatic interactions [1]. Because it does not form a covalent bond with the esteric site, its action is extremely short-lived (5–15 minutes) [1], [2]. **Analysis of Incorrect Options:** * **Option B (Esteric site):** This site is responsible for the actual hydrolysis of Acetylcholine. Organophosphates bind irreversibly to this site (phosphorylation) [2]. * **Option C (Both sites):** Carbamates (like Neostigmine and Physostigmine) bind to both the anionic and esteric sites [1]. They carbamylate the esteric site, leading to a longer duration of action compared to Edrophonium. * **Option D:** Incorrect, as Edrophonium is a competitive inhibitor that must bind to the enzyme to prevent the breakdown of Acetylcholine. **NEET-PG High-Yield Pearls:** 1. **Tensilon Test:** Edrophonium was historically used for the diagnosis of Myasthenia Gravis (MG) due to its rapid onset and short duration [2]. A positive test shows transient improvement in muscle strength. 2. **Differentiation:** It is used to differentiate a **Myasthenic crisis** (improvement with Edrophonium) from a **Cholinergic crisis** (worsening with Edrophonium) [2]. 3. **Structure:** Being a quaternary ammonium, it is polar and **does not cross the Blood-Brain Barrier (BBB)** [1]. 4. **Antidote:** Atropine should always be kept ready during a Tensilon test to manage potential bradycardia or excessive salivation.

Q: Which one of the following is a relatively selective 02 adrenergic blocker with a short duration of action?

Yohimbine. **Explanation:** The question asks for a selective **$\alpha_2$ adrenergic blocker** with a short duration of action. **Why Yohimbine is Correct:** Yohimbine is an alkaloid derived from the bark of the *Pausinystalia johimbe* tree. It acts as a **competitive, selective $\alpha_2$ receptor antagonist**. By blocking presynaptic $\alpha_2$ receptors, it increases the release of norepinephrine into the synaptic cleft, leading to increased sympathetic outflow. It has a relatively **short half-life (approx. 30–40 minutes)**, necessitating frequent dosing if used clinically. While historically used for erectile dysfunction, its clinical utility is now limited due to side effects like tachycardia and hypertension. **Why the Other Options are Incorrect:** * **Prazosin:** This is a highly selective **$\alpha_1$ blocker**. It is used in the treatment of hypertension and Benign Prostatic Hyperplasia (BPH). It is famous for the "first-dose phenomenon" (postural hypotension). * **Terazosin & Doxazosin:** These are also selective **$\alpha_1$ blockers** similar to Prazosin but have a much **longer duration of action** (Doxazosin has a half-life of ~22 hours), allowing for once-daily dosing. They are primarily used for BPH. **High-Yield NEET-PG Pearls:** * **$\alpha_2$ Agonists vs. Antagonists:** Remember that $\alpha_2$ agonists (Clonidine, Methyldopa) *decrease* sympathetic outflow, while $\alpha_2$ antagonists (Yohimbine, Idazoxan) *increase* it. * **Mirtazapine:** Another clinically important drug with $\alpha_2$ blocking properties, used as an atypical antidepressant. * **Reversal of Toxicity:** Yohimbine can theoretically be used to reverse the toxicity of $\alpha_2$ agonists like Xylazine (common in veterinary medicine). * **Selectivity Rule:** Drugs ending in **"-zosin"** are generally selective $\alpha_1$ blockers.

Q: Which antihistaminic agent possesses a high anticholinergic profile?

Diphenhydramine. **Explanation:** The correct answer is **Diphenhydramine**. **1. Why Diphenhydramine is correct:** Antihistamines are classified into first and second generations. **Diphenhydramine** is a **first-generation H1-receptor antagonist**. These agents are highly lipophilic (crossing the blood-brain barrier) and lack selectivity for the H1 receptor. They significantly antagonize **muscarinic receptors**, leading to a high anticholinergic profile. This results in classic side effects such as dry mouth, blurred vision, urinary retention, and constipation. **2. Why the other options are incorrect:** * **Astemizole & Terfenadine (Options A & C):** These are second-generation antihistamines. They were designed to be more selective for peripheral H1 receptors and have minimal to no anticholinergic activity. *Note: Both have been largely withdrawn from the market due to the risk of QT prolongation and Torsades de Pointes.* * **Fexofenadine (Option D):** This is a third-generation (or advanced second-generation) antihistamine and is the active metabolite of terfenadine. It is highly selective for peripheral H1 receptors, does not cross the blood-brain barrier, and is virtually devoid of anticholinergic effects. **3. NEET-PG High-Yield Pearls:** * **First-generation H1 blockers** (e.g., Diphenhydramine, Promethazine, Hydroxyzine) are used clinically for their sedative and anticholinergic properties (e.g., in motion sickness or Parkinsonism). * **Anticholinergic Toxidrome mnemonic:** "Blind as a bat, mad as a hatter, red as a beet, hot as a hare, dry as a bone." * **Fexofenadine** is the "least sedating" antihistamine because it is a substrate for the P-glycoprotein efflux pump in the blood-brain barrier. * **Drug Interaction:** Terfenadine and Astemizole toxicity increases when co-administered with CYP3A4 inhibitors (e.g., Ketoconazole, Erythromycin).

Question 1

Which of the following is NOT an effect of atropine?

Accepted Answer

Bradycardia

Answer

Rise of body temperature

Answer

Decreased salivary secretion

Answer

Increased A-V conduction

Question 2

In the beginning of resuscitation efforts, 0.5 mg of epinephrine is administered subcutaneously. Which adrenergic receptors, in which tissues, are responsible for the beneficial effect of epinephrine in this patient?

Accepted Answer

Alpha-1 receptors in vascular smooth muscle, beta-1 receptors in the heart, and beta-2 receptors in bronchial smooth muscle

Answer

Alpha-1 receptors in vascular smooth muscle, alpha-2 receptors in the heart, and beta-1 receptors in bronchial smooth muscle

Answer

Alpha-1 receptors in vascular smooth muscle, alpha-2 receptors at presynaptic nerve terminals, beta-1 receptors in bronchial smooth muscle

Answer

Alpha-2 receptors in vascular smooth muscle and beta-2 receptors in vascular smooth muscle

Question 3

What is the effect of vagal stimulation on the heart?

Accepted Answer

Increased RR interval in ECG

Answer

Increased heart rate

Answer

Increased cardiac output

Answer

Increased force of contraction

Question 4

Which glaucoma drug is a beta-1 selective beta-blocker?

Accepted Answer

Betaxolol

Answer

Timolol

Answer

Levobunolol

Answer

Carteolol

Question 5

What is the recommended treatment for atropine toxicity?

Accepted Answer

Physostigmine

Answer

2-Pralidoxime

Answer

Naloxone

Answer

Flumazenil

Question 6

Latanoprost is used for which of the following conditions?

Accepted Answer

Glaucoma

Answer

Maintenance of ductus arteriosus

Answer

Pulmonary hypertension

Answer

Gastric mucosal protection

Question 7

Edrophonium binds to which site of Acetylcholinesterase?

Accepted Answer

Anionic site

Answer

Esteric site

Answer

Both the sites

Answer

Doesn't bind to any site

Question 8

Which of the following drugs should be avoided in a patient with adrenaline-producing pheochromocytoma?

Accepted Answer

Phentolamine

Answer

Enalapril

Answer

Clonidine

Answer

Methyldopa

Question 9

Which one of the following is a relatively selective 02 adrenergic blocker with a short duration of action?

Accepted Answer

Yohimbine

Answer

Prazosin

Answer

Terazosin

Answer

Doxazosin

Question 10

Which antihistaminic agent possesses a high anticholinergic profile?

Accepted Answer

Diphenhydramine

Answer

Astemizole

Answer

Terfenadine

Answer

Fexofenadine

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?